The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost-effectiveness of single-day intravenous fosaprepitant versus three-day oral aprepitant anti-emetic regimen in pediatric patients receiving highly-emetogenic chemotherapy.
 
Manraj Singh Sra
No Relationships to Disclose
 
Azgar Abdul Rasheed
No Relationships to Disclose
 
Shuvadeep Ganguly
No Relationships to Disclose
 
Santosh Kumar
No Relationships to Disclose
 
Priya Sharma
No Relationships to Disclose
 
Ashwati S Pillai
No Relationships to Disclose
 
Swetambri Sharma
No Relationships to Disclose
 
DEEPAM PUSHPAM
Stock and Other Ownership Interests - caplin point laboratories
 
Sameer Bakhshi
Research Funding - AstraZeneca; Hetero; Intas; Roche India; Sellas Life Sciences